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Introduction
Bipolar disorder (BD) is associated with widespread abnor-
malities of white matter tracts, including the corpus callosum 
(CC).1–3 Microstructural impairments of white matter are in-
creasingly considered a relevant endophenotype for genetic 
studies in patients with BD,1 reinforcing the importance of 
large-scale neural network dysfunctions in the etiology and 
course of the disorder.2
The CC is the major interhemispheric white matter path-
way that includes about 200 million axons. Corpus callosum 
maturation begins in childhood and continues into early 
adulthood.4 In humans, the extensive bilateral projections of 
callosal fibres provide a unique pathway for interhemi-
spheric transfer. A meta-analysis has highlighted a reduction 
of the total mid-sagittal area of the CC in patients with BD.5 
However, results in patients with BD are more heterogen-
eous with respect to the area differences in the CC subre-
gional mid-sagittal areas, including their association with 
clinical features. Reduced posterior CC area is the most com-
monly reported difference between patients with BD and 
healthy controls.5–11 However, several studies have also re-
ported reduced areas of the anterior CC in patients with 
BD,7,8,10,12,13 while others have reported no such regional dif-
ference.14–17 These heterogeneous results may be partly ex-
plained by the phenotypic variability of patients with BD, 
such as the proportion of patients with psychotic features or 
mean illness duration, across studies.
Among the different clinical features of BD, there is a relative 
lack of exploration of the neuroimaging patterns associated with 
psychotic BD, which contrasts with the studies highlighting the 
relevance of the distinction of psychotic versus nonpsychotic BD 
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Background: Previous studies have reported MRI abnormalities of the corpus callosum (CC) in patients with  bipolar disorder (BD), al-
though only a few studies have directly compared callosal areas in psychotic versus nonpsychotic patients with this disorder. We sought 
to compare regional callosal areas in a large international multicentre sample of patients with BD and healthy controls. Methods: We an-
alyzed anatomic T1 MRI data of patients with BD-I and healthy controls recruited from 4 sites (France, Germany, Ireland and the United 
States). We obtained the mid-sagittal areas of 7 CC subregions using an automatic CC delineation. Differences in regional callosal areas 
between patients and controls were compared using linear mixed models (adjusting for age, sex, handedness, brain volume, history of 
alcohol abuse/dependence, lithium or antipsychotic medication status, symptomatic status and site) and multiple comparisons correction. 
We also compared regional areas of the CC between patients with BD with and without a history of psychotic features. Results: We in-
cluded 172 patients and 146 controls in our study. Patients with BD had smaller adjusted mid-sagittal CC areas than controls along the 
posterior body, the isthmus and the splenium of the CC. Patients with a positive history of psychotic features had greater adjusted area 
of the rostral CC region than those without a history of psychotic features. Limitations: We found small to medium effect sizes, and 
there was no calibration technique among the sites. Conclusion: Our results suggest that BD with psychosis is associated with a differ-
ent pattern of interhemispheric connectivity than BD without psychosis and could be considered a relevant neuroimaging subtype of BD.
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in clinical and genetic studies.18–20 In a recent study, we reported 
that BD with psychosis was associated with greater microstruc-
tural CC impairments than BD  without a history of psychosis.3 
However, to our knowledge only 2 studies have directly com-
pared callosal areas between these 2 subgroups, yielding nega-
tive results.15,21 Moreover, these studies included relatively lim-
ited samples, possibly leading to insufficient power to detect 
more subtle differences. Furthermore, they did not consider CC 
subdivisions. Consequently, it is largely unknown whether BD 
with psychotic features is associated with a different pattern of 
macrostructural regional callosal abnormalities than nonpsy-
chotic BD presentations.
In the present study, we thus aimed to compare regional 
callosal areas in patients with BD-I and healthy controls 
 using a relatively large sample derived from international 
multicentre sites. We also compared these regional areas in 
patients with BD with and without a positive history of psy-
chotic features in order to search for specific regional callosal 
differences associated with such features. We hypothesized 
that compared with controls, patients with BD would show 
decreases in CC areas and that these decreases would be 
more pronounced in patients with psychotic features.
Methods
Participants
We recruited patients with BD-I via clinical referral made by 
the regional psychiatric services from the 4 participating 
inter national, university-affiliated psychiatry departments: 
Assistance Publique Hôpitaux de Paris (Henri Mondor Hos-
pital, Créteil, France, and Fernand Widal-Lariboisière Hospi-
tal, Paris, France), the Western Psychiatric Institute and 
Clinic, UPMC (Pittsburgh, United States) and the Central In-
stitute for Mental Health (Mannheim, Germany) between 
2008 and 2011 and the Clinical Science Institute (Galway, 
 Ireland) between 2006 and 2008. Controls were matched to 
patients within each site and were recruited from local regis-
try offices and from media announcements.
All participants had to be between the ages of 18 and 
60 years, and BD-I was diagnosed using DSM-IV criteria. Ex-
clusion criteria were history of neurologic illness; contraindica-
tion to MRI; and alcohol use disorder or dependence within 
the participants’ lifetime (France, Germany), within the 
2 months preceding the study (United States), or within the 
year preceding the study (Ireland). In addition, controls were 
required to have no personal or family history of axis I mood 
disorders, schizophrenia or schizoaffective disorder. Partici-
pants were assessed by trained raters using the Diagnostic 
Inter view for Genetic Studies (French site)22 and the Structured 
Clinical Interview for DSM-IV (German, Irish and US sites).23
Symptoms of depression and mania were assessed using the 
Montgomery-Åsberg Depression Rating Scale (French and 
German sites)24 or the Hamilton Rating Scale for Depression 
(HAMD; 25-item version at the US site and 19-item version at 
the Irish site)25 and the Young Mania Rating Scale (all sites).26 
Two hundred participants took part in a diffusion-weighted 
tractography study in which structural T1 images were used 
only for registration purposes,3 and 120 took part in a voxel-
based structural analysis of grey and white matter.27 We de-
fined symptomatic patients as having a score greater than 7 on 
the mood scales, and we considered patients to have a positive 
history of psychotic features if they had at least 1 manic or de-
pressive episode with delusions or hallucinations.
All participants were given full verbal and written infor-
mation about the aims, methods and risks of this research, 
and were given the option to decline participation. They 
were invited to ask questions about the research and about 
the consent form, with replies contributing to ensuring their 
informed participation. Patients with enforced hospitaliza-
tion or under conservatorship were not included in the 
study, nor were patients in an active psychotic state that may 
have interfered with their ability to give informed consent. 
Such processes were assessed through clinical examination 
and consultation with the medical team involved in the pa-
tients’ care, as appropriate. After a complete description of 
the study each participant gave written informed consent.
The local ethics committees of each centre approved the 
study: the Ethical Committee of the Medical Faculty 
Mannheim, Heidelberg University (Germany), the NUI Gal-
way and the University College Hospital Galway research 
ethics committees (Ireland), the Institutional Review Board of 
the University of Pittsburgh (United States) and the Comité 
de Protection des Personnes Ile-de-France (France).
MRI data collection
Each participant underwent high-resolution 3-dimensional 
T1-weighted structural MRI using a Siemens Magnetom 
 TrioTim 3 T Syngo MR B17 scanner (Siemens Medical Solu-
tions) with a 12-channel head-coil at the French, German and 
US sites (echo time [TE] 2.98 ms, repetition time [TR] 
2300 ms, 160 slices, voxel size 1.0 × 1.0 × 1.0 mm or 1.1 mm) 
or a 1.5 T Siemens Magnetom Symphony scanner with a stan-
dard quadrature head coil at the Irish site (TE 4.38 ms, TR 
1140 ms, 160 slices, reconstructed, voxel size 0.9 × 0.9 × 
0.9 mm). Two of us (J.H. and S.S.) assessed images visually 
for artifacts and geometrical distortions affecting the CC.
Data processing
We estimated the regional areas of the CC following a 2-step 
method: the delineation of the CC on a resampled mid- 
sagittal slice and then its parcellation into 7 regional areas fol-
lowing Witelson’s scheme.28 To overcome biases related to 
manual delineations and extensive processing time, we used 
an automated segmentation software: the Automatic Regis-
tration Toolbox (ART) for CC, “yuki” module, version 2.0 for 
Linux (www.nitrc.org/projects/art/).29
Briefly, the yuki module of the ART for CC follows 4 steps 
for each participant to delineate the CC. These methods are 
described in depth elsewhere.29,30 The first step is the localiza-
tion of the mid-sagittal plane using a method designed to re-
duce the potential effects of head tilt. The second step is the 
localization of the anterior and posterior commissures on the 
mid-sagittal plane. Third, the software reconstructed the 
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mid-sagittal slice via trilinear interpolation and a reorienta-
tion (512 × 512 isotropic pixels of 0.5 × 0.5 mm), with the cen-
tre of the image being the midpoint between the anterior and 
posterior commissure and with the top–bottom axis and the 
left–right axis of the image corresponding to the superior– 
inferior axis and the anterior–posterior axes, respectively 
(Fig. 1A). Finally, the software delineated the CC in the mid-
sagittal slice with a method based on a multi-atlas model 
 using a nonlinear registration algorithm (Fig. 1B). The last 
step was the automated delineation of the CC in 7 regions 
following the geometrical method described previously28 
(Fig. 1C and 1D): the rostrum, genu, rostral body, anterior 
midbody, posterior midbody, isthmus and splenium of the 
CC (Fig. 1D). One of us (S.S.), who was blind to the diagnosis, 
checked all segmentations visually, resulting in the exclusion 
of 1 individual owing to a delineation error in the isthmus re-
gion. No manual correction was applied.
To check the reliability of the automatic segmentation tech-
nique, we performed manual regional parcellations of the CC 
in 20 random scans using ITK-SNAP 2.431 and following the 
geometrical method described previously.28 We found a high 
agreement among the areas of the CC that were automatic-
ally29 and manually determined (intraclass correlation coeffi-
cient = 0.98). Using the Brain Extraction Tool of the FMRIB 
FSL toolbox,32 we computed a skull-stripped image for each 
Participant. One of us (S.S.) inspected each brain extraction 
visually, and we calculated the total brain volume (TBV) 
based on this skull-stripped image for each participant.
Statistical analysis
We used linear mixed models to compare the area of each re-
gion of the CC between patients with BD and controls and be-
tween patients with and without a positive history of psy-
chotic features. Diagnosis (BD v. control or BD with v. without 
psychotic features) was included as a factor of interest. We 
considered the following variables that are potentially associ-
ated with callosal area differences: sex; handedness; antipsy-
chotic and lithium medication status (yes v. no);33 history of al-
cohol abuse/dependence (yes v. no);34 and acute mood 
symptoms, defined as scores greater than 7 on mood rating 
scales (yes v. no). These variables were included as fixed- effect 
factors. Age and TBV were included as fixed-effect covariates, 
while site was included as a random-effect factor in order to 
control for specific site-related effects. In addition, illness dura-
tion was included as a fixed-effect covariate in the model when 
comparing patients with and without a history of psychosis.
We tested differences between continuous and categorical 
demographic variables using Student t tests and Pearson χ2 
tests, respectively, if appropriate assumptions were met. 
Fig. 1: Illustration of the automated processing pipeline for 1 participant. (A) Reoriented midsaggital slice. (B) Automatic local-
ization of the anterior commissure (green cross) and of the posterior commissure (red cross). Automatic delineation of the cor-
pus callosum based on a multiatlas model (white border, blue crosses). (C and D) Automatic segmentation of the corpus callo-
sum based on the geometrical method described by Witelson and colleagues.28
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Correlations between the callosal areas and the duration of 
illness were assessed using the Spearman partial correlation 
test while controlling for TBV. We used PASW software 
version 18 for data analysis. We considered results of com-
parisons of demographic data and CC areas to be significant 
at p < 0.05, false-discovery rate (FDR)–corrected. We calcu-
lated corrected p values using R 2.15.1, Multitest package 
(www.r-project.org). All the analyses were performed after 
outlier detection using leaf plots. Deviation from normality 
was detected for 3 regional areas. To respect the statistical 
assumption of normal distribution of residuals when using 
linear mixed models, we performed analyses on trans-
formed areas using natural logarithmic transformation,35 
which we checked for the normality of residues using the 
Kolmogorov–Smirnov test and qq plots. To further enable 
reader clarity, raw mean areas are presented. To exclude an 
effect of the transformation, untransformed data are also 
shown (Appendix 1, available at jpn.ca).
Results
Sample
The sample included 174 patients with BD and 146 controls. 
Information about alcohol lifetime abuse/dependence was 
missing for 2 patients; therefore, the final sample comprised 
172 patients and 146 controls. Demographical data are sum-
marized in Table 1.
Patients and control groups did not differ significantly in 
age, sex, handedness and TBV. Mean years of education was 
16.4 ± 3.4 for controls and 14.7 ± 3.2 for patients at the Galway 
and Mannheim sites. Categorical data about level of education 
were missing for 16 patients at the US and Créteil sites. Level 
of education was at least high school diploma in 64 (97.0%) pa-
tients and 39 (95.1%) controls and below high school diploma 
in 2 (3.0%) patients and 2 (4.9%) controls. Regarding medica-
tion on the day of scanning, 84 (48.3%) patients were being 
treated with lithium salts, 91 (52.3%) with first- or second- 
generation antipsychotics, 88 (50.6%) with anticonvulsants, 61 
(35.1%) with antidepressants and 90 (51.7%) with a combina-
tion of medications, including at least 2 mood stabilizers.
Data concerning the history of psychotic features was 
missing for 1 patient, while mood assessment confirmed that 
35 (20.1%) patients were symptomatic on the day of scanning.
Comparison of callosal areas
We found significant reductions in the mid-sagittal areas of 
the posterior body, isthmus and splenium of the CC in 
patients versus healthy controls (Table 2). Patients with a 
positive history of psychotic features had a significantly 
larger CC rostrum area than patients without a history of 
psychotic features (Table 3).
Post hoc analyses
After controlling for TBV, there were no significant partial 
correlations between the duration of illness and the areas of 
the posterior midbody (partial correlation = 0.019, p = 0.80), 
isthmus (partial correlation = –0.032, p = 0.67) and splenium 
(partial correlation = 0.052, p = 0.50) in patients with BD. 
When examining the subgroups and controlling for TBV, 
there was a significant positive correlation between the area 
of the rostrum and the duration of illness in patients with a 
Table 1: Demographic and clinical characteristics of the study sample
Group; no. (%) or mean ± SD
Characteristic BD, n = 172 Control, n = 146 Statistic p value
Women 95 (55.2) 74 (50.7) χ21,318 = 0.656 0.67
Right-handed 161 (93.6) 139 (95.2) χ22,318 = 0.382 0.87
Site χ23,318 = 6.621 0.27
1) France 23 (13.4) 22 (15.1)
2) United States 52 (30.2) 26 (17.8)
3) Germany 37 (21.5) 38 (26.0)
4) Ireland 60 (34.9) 60 (41.1)
History of psychotic features* 113 (65.7) — — —
Positive history of alcohol abuse or dependence 35 (20.3) — — —
Age at MRI, yr 37.9 ± 10.41 39.2 ± 10.8 t316 = 1.016 0.67
Age at onset, yr 23.4 ± 8.8 — — —
Duration of illness, yr 14.54 ± 9.1 — — —
MADRS score (2 sites) 3.2 ± 4.8 — — —
HAMD-19 score (1 site) 4.96 ± 7.1 — — —
HAMD-25 score (1site) 12.58 ± 10.24 — — —
YMRS score (4 sites) 1.8 ± 3.2 — — —
Brain volume, cm3 1429.2 ± 153.5 1437.9 ± 145.7 t316 = 0.521 0.72
BD = bipolar disorder; HAMD = Hamilton Rating Scale for Depression; MADRS = Montgomery–Åsberg Depression Rating Scale; SD = standard deviation; YMRS = Young 
Mania Rating Scale.
*Data on psychotic features missing for 1 participant.
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positive history of psychotic features (partial correlation = 
0.242, p = 0.010) but not in those without a history of psy-
chotic features (partial correlation = –0.054, p = 0.69).
Discussion
We found a reduced area in 3 posterior parts of the CC in pa-
tients with BD compared with controls: the posterior midbody, 
isthmus and splenium. Patients with a positive history of psy-
chotic features had an increased area of the CC rostrum com-
pared with patients who never experienced psychotic symp-
toms during illness phases. To our knowledge, this is the first 
multicentre study and the largest sample used to explore callo-
sal areas in patients with BD using structural T1 MRI and the 
first to report a difference in callosal morphology between pa-
tients with with and without a history of psychosis.
Table 2: Comparison of callosal regional areas between patients with bipolar disorder I and healthy controls*
BD, n = 172 Control, n = 146
Region No.†
Area, mm2; 
raw mean 
± SD
Area, log 
scale; raw 
mean ± SD No.†
Area, mm2; 
raw mean 
± SD
Area, log 
scale; raw 
mean ± SD)
Estimated adjusted 
group difference; 
log scale (95% CI) Statistic
p 
value‡
Partial η2
for 
diagnosis
Significant 
cofactors/ 
covariates 
(partial η2)
Rostrum 169 25.67 ± 
8.89
3.19 ± 0.34 146 24.48 ± 
8.99
3.13 ± 0.36 0.044  
(–0.067 to 0.155)
F1,301 = 
0.607
0.67 0.002 Age (0.065)
TBV (0.032)
Genu 170 132.72 ± 
27.94
4.87 ± 0.21 142 138.29 ± 
22.0
4.92 ± 0.16 –0.049  
(–0.109 to 0.010)
F1,298 = 
2.643
0.28 0.009 TBV (0.124)
Rostral 
body
168 92.78 ± 
16.20
4.51 ± 0.17 141 93.29 ± 
14.06
4.52 ± 0.15 0.003 
(–0.048 to 0.054)
F1,295 = 
0.013
0.91 < 0.001 TBV (0.090)
Anterior 
midbody
170 70.31 ± 
12.40
4.24 ± 0.17 143 73.59 ± 
10.04
4.29 ± 0.14 –0.050 
(–0.099 to –0.001)
F1,299 = 
4.007
0.17 0.013 TBV (0.116)
Posterior 
midbody
168 59.90 ± 
10.90
4.08 ± 0.18 144 63.92 ± 
9.43
4.15 ± 0.15 –0.082 
(–0.133 to –0.030)
F1,298 = 
9.771
0.019 0.032 Site (0.038)
TBV (0.087)
Isthmus 171 50.89 ± 
12.64
3.90 ± 0.25 145 57.07 ± 
11.91
4.02 ± 0.21 –0.119 
(–0.191 to –0.047)
F1,302 = 
10.496
0.019 0.034 TBV (0.093)
Splenium 168 180.07 ± 
28.66
5.18  ± 0.16 144 190.28 ± 
24.55
5.24 ± 0.13 –0.071 
(–0.117 to –0.024)
F1,298 = 
9.057
0.019 0.029 TBV (0.114)
BD = bipolar disorder; CI = confidence interval; SD = standard deviation; TBV = total brain volume. 
*Analyses were controlled for age, sex, handedness, site, past alcohol abuse or dependence, lithium and antipsychotic medication status (yes v. no), symptomatic status (yes v. no) and 
TBV and were conducted after exclusion of outliers. 
†Without outliers. 
‡False-discovery rate–corrected.
Table 3: Comparison of callosal regional areas between patients with a positive history of psychotic features and patients without such a history*
BD with psychotic features,  
n = 113
BD without psychotic features, 
n = 58
Region No.†
Area, 
mm2; raw 
mean ± 
SD
Area, log 
scale; raw 
mean ± 
SD No.†
Area, 
mm2; raw 
mean ± 
SD
Area, log 
scale; raw 
mean ± 
SD)
Estimated adjusted 
group difference; 
log scale (95% CI) Statistic
p 
value‡
Partial η2
for 
diagnosis
Significant 
cofactors/ 
covariates 
(partial η2)
Rostrum 112 26.84 ± 
9.61
3.23 ± 
0.36
56 23.40 ± 
6.90
3.11 ± 
0.29
0.167  
(0.043 to 0.292)
F1,153 = 7.025 0.043 0.044 Site (0.068)
Age (0.079)
TBV (0.036)
Genu 113 133.55 ± 
29.33
4.87 ± 
0.22
56 131.16 ± 
25.36
4.86 ± 
0.20
–0.031  
(–0.107 to 0.046)
F1,154 = 0.631 0.67 0.004 TBV (0.171)
Rostral 
body
110 92.79 ± 
16.24
4.52 ± 
0.17
57 92.58 ± 
16.34
4.51 ± 
0.17
0.020  
(–0.043 to 0.084)
F1,152 = 0.394 0.67 0.003 Site (0.063)
TBV (0.050)
Anterior 
midbody
112 71.12 ± 
12.20
4.25 ± 
0.17
56 69.29 ± 
12.48
4.22 ± 
0.18
0.026  
(–0.037 to 0.089)
F1,153 = 0.672 0.67 0.004 TBV (0.129)
Posterior 
midbody
112 60.28 ± 
11.13
4.08 ± 
0.18
57 58.25 ± 
11.29
4.05 ± 
0.19
0.023  
(–0.044 to 0.090)
F1,154 = 0.447 0.67 0.003 TBV (0.122)
Isthmus 112 50.99 ± 
12.50
3.90 ± 
0.24
56 51.26 ± 
12.37
3.91 ± 
0.24
–0.029  
(–0.116 to 0.057)
F1,153 = 0.445 0.67 0.003 TBV (0.132)
Splenium 110 180.85 ± 
28.50
5.18 ± 
0.16
57 178.16 ± 
29.22
5.17 ± 
0.16
–0.018  
(–0.105 to 0.070)
F1,152 = 0.159 0.77 0.001 TBV (0.125)
BD = bipolar disorder; CI = confidence interval; SD = standard deviation; TBV = total brain volume. 
*Analyses were controlled for age, sex, handedness, site, past alcohol abuse or dependence, lithium and antipsychotic medication status (yes v. no), symptomatic status (yes v. no), 
duration of illness and TBV and were conducted after exclusion of outliers. Data about psychotic features missing for 1 patient with bipolar disorder. 
†Without outliers. 
‡False-discovery rate–corrected. 
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Comparisons of callosal areas between patients with BD 
and controls
In accordance with previous findings, patients with BD had 
reduced areas of 3 posterior CC regions compared with 
healthy controls.5–9,11 As the CC follows a topographical org-
an ization,4 reductions of the posterior areas suggest that BD 
may be associated with decreased interhemispheric connec-
tivity between  homologous regions wired through the pos-
terior callosum (i.e., parietal, temporal and occipital cortices).36 
Interestingly, a growing number of diffusion MRI studies 
have independently reported microstructural CC alterations 
in patients with BD,1–3,27,37 suggesting that callosal abnormal-
ities are identifiable both at a macrostructural and microstruc-
tural level in these patients. This may overlap with data in pa-
tients with callosal agenesis, who can exhibit severe 
behavioural symptoms, including manic or depressive symp-
tomatology.38 Taken together, these and similar results suggest 
an important role for CC structural abnormalities in driving 
impaired interhemispheric integration in patients with BD.
Despite such growing bodies of evidence, however, the 
functional consequences of these alterations have remained 
relatively poorly explored, resulting in little attempt to inte-
grate interhemispheric dysconnectivity in most recent BD 
neuro biological models.2 Future functional connectivity 
 studies based on emotional and cognitive tasks that involve 
interhemispheric transfer are warranted in order to improve 
our understanding of the clinical manifestations of decreased 
interhemispheric integration in  patients with BD.
Comparisons of callosal areas between patients with and 
without a history of psychotic features
A comparison of patient subgroups according to their history 
of psychotic features showed greater CC rostral areas in pa-
tients with a history of psychotic features than in those without 
such a history. Previous studies have directly compared psy-
chotic and nonpsychotic patients with BD, although these 
studies were limited by comparisons restricted to total CC 
area, where no significant differences were evident.15,16 
 Walterfang and colleagues21 compared callosal metrics be-
tween 46 patients with and 24 patients without psychosis and 
found no difference in total callosal area, length or curvature. 
These authors subsequently replicated this result15 in a smaller 
sample of 10 patients with and 11 patients without psychosis. 
Our results are from a larger sample and suggest a different 
pattern of anterior interhemispheric connectivity in patients 
with BD that depends on their history of psychotic symptoms.
The rostral part of the CC is thought to include white matter 
fibres that link the orbitofrontal cortices (Brodmann area [BA] 
11/47), the lateral prefrontal cortices (BA 45/746) and the 
medi al prefrontal cortices (BA 10) bilaterally.36 Interestingly, all 
of these regions are highly involved in emotion processing and 
regulation and have been associated with BD pathology in 
functional neuroimaging studies.2 At a cellular level, increased 
CC areas have been associated with higher axonal density, 
particularly in anterior and posterior areas where small unmy-
elinated fibres predominate.4 However, whether this increased 
connectivity of the rostral CC is specific to BD with psychotic 
features or whether it is shared with other diagnoses across the 
psychosis spectrum requires further investigation. To our 
knowledge, only 1 study has looked at this question, directly 
comparing patients with a first episode of affective psychosis 
(BD with psychosis or major depressive disorder with psycho-
sis) with patients with schizophrenia-spectrum disorder, re-
porting no between-group difference of the total callosal area.16 
However, future studies comparing callosal subregional areas 
using a dimensional measure of psychosis across different 
diag noses will be necessary to clarify whether the results here 
are typical of psychosis more generally. Moreover, histological 
studies are warranted to understand the cellular and molecu-
lar underpinnings of the differences in callosal areas between 
subgroups of patients with BD.
Association between callosal areas and illness duration
Previous reports have suggested that callosal abnormalities 
may be linked to a disease-related process rather than being a 
BD vulnerability trait. Several studies have suggested that 
morphological12,21 and microstructural callosal abnormal ities39 
may be patient-specific. Other groups have proposed that the 
CC is more susceptible to aging in patients with BD.6–9,11 Here, 
in a relatively large sample, we found a positive association 
between the CC rostral area and illness duration, but only in 
the BD subgroup with a positive history of psychosis, ad-
justed for TBV. This correlation was absent in other CC re-
gions. Importantly, rostral area differences between patients 
with and without psychosis remained significant even after 
adjusting for illness duration. This could suggest a different 
disease-related callosal remodelling across the course of the 
illness between these 2 subgroups. Further, it could suggest 
the differential involvement of the rostral CC in patients with 
BD with and without psychotic features. However, longitud-
inal studies including the period before illness onset are 
needed to characterize the evolution of structural CC rostral 
area changes in patients with BD with and without psychotic 
features, as highlighted by our results.
Effects of potential confounders
Several studies have explored the influence of lithium salts 
and antipsychotics on callosal measurements, yielding con-
flicting results.12,16,21 In our sample there was no evidence of a 
confounding effect of lithium or antipsychotics on the results. 
Neurotoxic effects of alcohol abuse may bias assessments of 
white matter volumes;34 however, this was controlled for in 
the statistical analysis, as was symptomatic status on the day 
of MRI acquisition, thereby avoiding any effect of acute 
symptomatology on our measurements.
Strengths and limitations
Several strengths of our study should be emphasized. First, to 
our knowledge, this is the first multicentre assessment of re-
gional CC areas in a large sample of patients with BD and 
healthy controls. Second, the analyses accounted for a number 
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of potentially confounding variables — site of inclusion, sex, 
age, handedness and TBV of the participants — with the signifi-
cance of the results FDR-corrected. Third, we used an automatic 
parcellation technique, thereby reducing biases related to man-
ual CC delineation. Fourth, we investigated the influence of sev-
eral clinical variables, such as a history of alcohol abuse, effect of 
mood on the day of scanning, and lithium or antipsychotic 
medi cations, all of which might have biased the results.
Despite these advantages our study has several limitations. 
We found only small to medium effect sizes, in contrast to 
other studies based on smaller samples. However, small sam-
ples may lead to overestimated effect sizes.40 Methodologic-
ally, there was no calibration technique among the sites. 
However, we corrected for site in our statistical analysis. 
 Final ly, although the confounding effect of current lithium 
and antipsychotic medications was ruled out, the effects of 
past medication cannot be excluded.
Conclusion
We conducted a structural assessment of regional callosal 
 areas in patients with BD and controls using T1 MRI in a rela-
tively large sample. We identified reduced areas in 3 contigu-
ous posterior regions of the CC in patients with BD compared 
with controls. The BD subgroup with psychotic features 
showed an increased CC rostral area. These findings support 
the hypothesis of impaired interhemispheric connectivity in 
temporal and posterior parts of the brain in patients with BD. 
Furthermore, our results provide neuroimaging evidence that 
BD with psychotic features may be a relevant neuroimaging 
subtype of BD with a different pattern of callosal abnormal-
ities. Future neuroimaging studies assessing the histological 
correlates of these differences (e.g., using axonal calibration 
techniques) and the functional consequences of these abnor-
malities (e.g., functional connectivity during emotional tasks 
with cross–uncrossed conditions) are needed to clarify the cel-
lular underpinnings and the functional consequences of inter-
hemispheric connectivity impairments in patients with BD.
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